ArticleJournal of inflammation (London, England)2025

Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort study.

Conor B Driscoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.